Replies to post #21557 on Biotech Values

[the_busy_ant]

ADH?

At some level, I think you've lost your mind. However, these things seem to work out for you (c.f. GENR), so what do I know.
Too much risk for my tastes, no matter how "good" the valuation seems. The whole cadherin business seems like yet another shot in the dark to me. And the fancy uracil analog? Cross your fingers...

BTW, Not that this has any major relevance within the article you posted, but Mal Steinberg never won the Nobel Prize. He's a bit of a huckster (MHO).